Name | Type | Posted | Actions |
|---|---|---|---|
FDA Sources Sought Notice 75F40126SSNFY26_MCC.pdf | Apr 6, 2026 | ||
Attachment 3-E1230 - BUILDING 62 - SECOND FLOOR PLANS - DEMOLITION AND NEW.pdf | Apr 6, 2026 | ||
ATTACHMENT 1-E1210 - BUILDING 62 - FIRST AND BASEMENT FLOOR PLANS AND ONE-LINE DIAGRAM - DEMOLITION.pdf | Apr 6, 2026 | ||
Attachment 4-E1240 and E1250 - Elevations Schedules and Notes.pdf | Apr 6, 2026 | ||
Attachment 2-E1220 - BUILDING 62 - FIRST AND BASEMENT FLOOR PLANS AND ONE-LINE DIAGRAM - NEW.pdf | Apr 6, 2026 |
FDA NCTR Bldg. 62 MCC-Switchgear Replacement
Contact and place of performance
Tim Walbert
Jefferson, AR 72079
USA
This is a Sources Sought Notice (SSN) - a market survey designed to collect written information only. This is not a solicitation announcement for proposals and no contract will be awarded from this announcement. No reimbursement will be made for any costs associated with providing information in response to this announcement or any follow-up information requests. There is no RFQ, or other iteration of a solicitation...
View moreIf your firm is actively registered in SAM as a small business source under North American Industry Classification System (NAICS) code 238210 (Electrical Contractors and Other Wiring Installation Contractors), with a size standard of $19.0 million, and you believe that your firm would be able to provide the FDA with the commercial construction services described below, please submit an email containing a capability statement to [email protected] by the date and time specified on the last page of this Notice. Other than small business concerns are also encouraged to submit capability statements.
Period of Performance
Estimated period of performance is 24 months after official Notice to Proceed.
Place of Performance
The equipment is located at the National Center for Toxicological Research (NCTR) at the following address:
U.S. Food and Drug Administration (FDA)
National Center for Toxicological Research (NCTR)
3900 NCTR Rd., Bldg. 62
Jefferson AR 72079
Responses to this Sources Sought shall unequivocally demonstrate that the respondent is regularly engaged in the performance of the services required herein. Though the target audience is small business vendors or small businesses capable of supplying a U.S. product/service of a small business vendor or producer, all interested parties may respond in the form of a capabilities statement. At a minimum, capability statements shall include the following:
The Government is not responsible for locating or securing any information not identified in the response.
Disclaimer and Important Notes
This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work.
Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre‐solicitation synopsis or combined synopsis/ solicitation may be published on SAM.gov – Contracting Opportunities. However, responses to this notice will not be considered a response to a solicitation.
Confidentiality and Proprietary Information
No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non‐proprietary technical information in any resultant solicitation(s).
Interested firms must respond with capability statements submitted ONLY by email on or before 2:00 pm (Central Time in Jefferson AR) on April 21, 2026 to Tim Walbert at [email protected]. Please reference FDA SSN 75F40126SSNMCC62 in the Subject line of the e-mail.
Attachments: Building 62 plan documents (5 PDF files):
Attachment No. Plan ID Description
1 E1210 First Floor and Basement Plans – one-line diagram DEMOLITION
2 E1220 First Floor and Basement Plans – one-line diagram NEW
3 E1230 Second Floor Plans – DEMOLITION and NEW
4 E1240, E1250 Elevations, Schedules, and Notes
The Food and Drug Administration (FDA) is conducting market research through this Sources Sought Notice to identify capable sources for an electrical infrastructure project at the National Center for Toxicological Research in Jefferson, Arkansas. The scope of work involves replacing motor control centers, switchgear equipment, and draw-out breakers in Building 62, where much of the existing equipment dates back to the 1940s and 1950s. The required services include the installation and testing of new breakers as well as the performance of arc-flash studies and thermal scanning on all replaced components.
This requirement is identified under solicitation number 75F40126SSNFY26_MCC and is classified under NAICS 238210, Electrical Contractors and Other Wiring Installation Contractors, and PSC Z1HB, Maintenance of Government-Owned Government-Operated (GOGO) R&D Facilities. There is currently no set-aside designated for this notice, noted as set-aside acronym NONE. The estimated period of performance for the project is 24 months after the issuance of an official Notice to Proceed. Documentation for the project includes five attachments consisting of floor plans, one-line diagrams, elevations, and schedules for the demolition and installation phases.
Capability statements are due by April 21, 2026, and must be submitted to the point of contact, Tim Walbert. Submissions should include business identifiers, past performance on similar electrical projects involving antiquated equipment from the last three years, and standard commercial warranty terms. Although the government is primarily seeking information on small business sources, all interested firms are encouraged to respond to assist with market research and the determination of future acquisition strategies.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.